Analysis: Big Pharma down, not out, after Indian patent blow

By Ben Hirschler and Kaustubh Kulkarni LONDON/MUMBAI (Reuters) – Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016. Makers of patented drugs will in future have to get more creative about doing business in India, including striking deals with local firms to sell cheaper versions of their drugs, industry experts believe. …